Stem Cell Transplant Types for T-Cell Leukemia in Remission
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study compares two types of stem cell transplants for people with T-lymphoblastic leukemia or lymphoma who have responded well to chemotherapy. The goal is to see which approach—using your own stem cells or donor cells—works better and is safer for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 55 years old
- Your T-cell leukemia or lymphoma is in first complete remission (meaning chemotherapy worked and cancer is no longer detectable)
- Your heart, lungs, kidneys, and liver are working well enough for the transplant procedure
- You do not have active infections like HIV, hepatitis B or C, or syphilis
- You have not had another cancer in the past 5 years (with some exceptions for skin cancer and certain other treated cancers)
- You are able to understand the study and willing to sign consent and follow all study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of stem cell transplants (one using donor cells, the other using your own cells) to see which works better for adults with a certain stage of T-cell lymphoma who have already responded well to initial chemotherapy.
This study compares two types of stem cell transplants (from a donor or your own cells) for people with certain T-cell lymphomas who had only a partial response to first chemotherapy. It aims to see which approach may work better.
This trial tests a stem cell transplant using a half-matched family donor for children with acute lymphoblastic leukemia (ALL) that is in remission. It compares two different types of radiation conditioning to prepare the body for the new cells, with the goal of improving outcomes.
This Phase 2 study looks at a specific type of stem cell transplant that uses donor stem cells with immune cells removed, to treat certain high-risk leukemias and lymphomas. It aims to reduce relapse risk and improve outcomes in people who may need a transplant but have specific disease features.
This trial tests whether high-dose chemotherapy followed by a stem cell transplant using your own cells can help people with certain types of peripheral T-cell lymphoma live longer. You would qualify if you have already finished your first round of chemotherapy and are in complete remission.
This trial studies whether doing an autologous stem cell transplant (using your own stem cells) after a complete response helps people with certain T-cell lymphomas stay in remission longer. It may be an option if your lymphoma has shrunk completely and you fit the safety and testing requirements.
Hear when a new T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.